Your browser doesn't support javascript.
loading
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
Beltran, Himisha; Romanel, Alessandro; Conteduca, Vincenza; Casiraghi, Nicola; Sigouros, Michael; Franceschini, Gian Marco; Orlando, Francesco; Fedrizzi, Tarcisio; Ku, Sheng-Yu; Dann, Emma; Alonso, Alicia; Mosquera, Juan Miguel; Sboner, Andrea; Xiang, Jenny; Elemento, Olivier; Nanus, David M; Tagawa, Scott T; Benelli, Matteo; Demichelis, Francesca.
Afiliação
  • Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Romanel A; Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, New York, USA.
  • Conteduca V; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Casiraghi N; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Sigouros M; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Franceschini GM; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Orlando F; Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, New York, USA.
  • Fedrizzi T; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Ku SY; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Dann E; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Alonso A; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Mosquera JM; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Sboner A; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA.
  • Xiang J; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA.
  • Elemento O; Department of Pathology and Laboratory Medicine, and.
  • Nanus DM; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA.
  • Tagawa ST; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA.
  • Benelli M; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA.
  • Demichelis F; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA.
J Clin Invest ; 130(4): 1653-1668, 2020 04 01.
Article em En | MEDLINE | ID: mdl-32091413
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Regulação Neoplásica da Expressão Gênica / Carcinoma Neuroendócrino / Metilação de DNA / Epigênese Genética / Neoplasias de Próstata Resistentes à Castração / DNA Tumoral Circulante / Proteínas de Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Regulação Neoplásica da Expressão Gênica / Carcinoma Neuroendócrino / Metilação de DNA / Epigênese Genética / Neoplasias de Próstata Resistentes à Castração / DNA Tumoral Circulante / Proteínas de Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article